Insider Buying: Senestech (NASDAQ:SNES) Major Shareholder Acquires 181,252 Shares of Company Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management purchased 181,252 shares of the stock in a transaction dated Friday, October 16th. The shares were acquired at an average cost of $0.63 per share, with a total value of $114,188.76. Following the acquisition, the insider directly owned 1,686,546 shares in the company, valued at $1,062,523.98. This represents a 12.04% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Monday, October 19th, Glenbrook Capital Management acquired 376,552 shares of Senestech stock. The shares were acquired at an average price of $0.70 per share, with a total value of $263,586.40.
• On Thursday, October 15th, Glenbrook Capital Management acquired 426,000 shares of Senestech stock. The shares were acquired at an average price of $0.77 per share, with a total value of $328,020.00.
• On Friday, August 7th, Glenbrook Capital Management acquired 6,490 shares of Senestech stock. The stock was acquired at an average cost of $1.30 per share, for a total transaction of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management bought 15,000 shares of Senestech stock. The stock was acquired at an average price of $1.30 per share, for a total transaction of $19,500.00.

Senestech Price Performance

NASDAQ SNES traded up $0.05 during trading on Monday, hitting $0.70. 1,245,150 shares of the company’s stock were exchanged, compared to its average volume of 375,681. The stock’s 50 day moving average price is $0.93 and its two-hundred day moving average price is $1.34. Senestech, Inc. has a fifty-two week low of $0.55 and a fifty-two week high of $4.04. The company has a current ratio of 6.78, a quick ratio of 5.81 and a debt-to-equity ratio of 0.02. The company has a market cap of $3.79 million, a PE ratio of -0.51 and a beta of 0.25.

Senestech (NASDAQ:SNES) last announced its quarterly earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.37) by $0.02. The company had revenue of $0.77 million for the quarter, compared to analyst estimates of $0.60 million. Senestech had a negative net margin of 294.73% and a negative return on equity of 71.89%. Research analysts expect that Senestech, Inc. will post -1.28 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut shares of Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, August 11th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Senestech has a consensus rating of “Sell”.

Hedge Funds Weigh In On Senestech

A hedge fund recently bought a new stake in Senestech stock. Diversify Wealth Management LLC purchased a new stake in shares of Senestech, Inc. (NASDAQ:SNES) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned approximately 0.36% of Senestech at the end of the most recent quarter. Hedge funds and other institutional investors own 5.19% of the company’s stock.

Senestech Company Profile

SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company’s approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.

SenesTech’s primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.